Literature DB >> 30168181

Infant onset severe complement-mediated hemolytic uremic syndrome complicated by secondary sclerosing cholangitis.

Osman Yesilbas1, Esra Sevketoglu1, Mey Talip Petmezci1, Hasan Serdar Kihtir1, Meryem Benzer2, Cigdem Arikan3, Afig Berdeli4, Huseyin Baloglu5, Ozdil Baskan6.   

Abstract

Entities:  

Keywords:  eculizumab, secondary sclerosing cholangitis; hemolytic uremic syndrome; therapeutic plasma exchange

Mesh:

Substances:

Year:  2018        PMID: 30168181     DOI: 10.1002/jca.21651

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


× No keyword cloud information.
  1 in total

1.  Acute Myocarditis and Eculizumab Caused Severe Cholestasis in a 17-Month-Old Child Who Has Hemolytic Uremic Syndrome Associated with Shiga Toxin-Producing Escherichia coli.

Authors:  Osman Yesilbas; Can Yilmaz Yozgat; Nurver Akinci; Sirin Sonmez; Eser Tekin; Faraz Talebazadeh; Uzeyir Jafarov; Hafize Otcu Temur; Yilmaz Yozgat
Journal:  J Pediatr Intensive Care       Date:  2020-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.